首页> 外文期刊>中国神经再生研究(英文版) >Differential protein expression in substantia nigra induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in a mouse model of chronic Parkinson's disease
【24h】

Differential protein expression in substantia nigra induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in a mouse model of chronic Parkinson's disease

机译:1-甲基-4-苯基-1,2,3,6-四氢吡啶在慢性帕金森病小鼠模型中诱导的黑质中差异蛋白表达

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: To date, a complete protein expression profile of the midbrain substantia nigra in a mouse model of chronic Parkinson's disease, induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP), does not exist. In addition, there are no reports of analysis of differential protein expression.OBJECTIVE: To separate and evaluate MPTP-induced differential protein expression through the use of proteomics in the substantia nigra of a mouse model of chronic Parkinson's disease.DESIGN: Randomized controlled animal study.SETTING: Department of Neurology, the First Affiliated Hospital, Chongqing Medical University.MATERIALS: Sixteen 8-10-week old, healthy, male, C57BL mice, weighing 20-25g, and of clean grade, were provided by the Experimental Animal Center of Chongqing Medical University. The experimental animals were disposed according to ethical criteria. MPTP was provided by Sigma Company, USA; Pdquest 2D image analysis software and gelatum/irradiance image analysis system (ChemiDoc XRS) by Bio-Rad, USA; and Voyager DE-PROMALDI-TOF-MS mass spectroscopy analyzer by ABI Company, USA.METHODS: This study was performed in Chongqing Neurological Laboratory between November 2006 and July 2007. Mice were randomly divided into model and control groups, with 8 mice in each group. Mice in the model group were Received a subcutaneous injection of MPTP (25mg/kg), twice a week, for five successive weeks, to establish a chronic Parkinson's disease model. Mice in the control group 收稿日期 the same volume of a subcutaneous saline injection at the same time points. Mice were sacrificed by anesthesia to rapidly obtain the midbrain for protein separation of the substantia nigra.MAIN OUTCOME MEASURES: (1) 2-ED handbook (Bio-Rad Company) was referenced for two-dimensional electrophoresis. (2) PDQUEST8.0 analytical electrophoresis pattern was adopted to evaluate differential protein expression. (3) Peptide mass finger print map and data were retrieved on http://www.prospector.ucsf.edu to compare differential substantia nigral protein expression in the two groups.RESULTS: Two-dimensional gel electrophoresis of substantia nigra tissue indicated that there were 33 differential protein expressions between the two groups. Three new proteins were evaluated, including α-enolase, which exhibited regulated expression, tumor necrosis factor ligand superfamily member 4, and cyclin-dependent kinase inhibitor 1B.CONCLUSION: There are three proteins that exhibit differential expression in the substantia nigra-α-enolase, tumor necrosis factor ligand superfamily member 4, and cyclin-dependent kinase inhibitor 1B.
机译:背景:迄今为止,尚不存在由1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的慢性帕金森氏病小鼠模型中中脑黑质的完整蛋白质表达谱。此外,尚无关于差异蛋白表达分析的报道。目的:通过蛋白质组学在慢性帕金森氏病小鼠模型的黑质中使用蛋白质组学来分离和评估MPTP诱导的差异蛋白表达。设计:随机对照动物研究地点:重庆医科大学附属第一医院神经内科材料:实验动物中心提供了16只8-20周龄,健康的雄性C57BL小鼠,体重20-25g,等级为纯净。重庆医科大学学报。根据伦理标准处置实验动物。 MPTP由美国Sigma公司提供;美国Bio-Rad的Pdquest 2D图像分析软件和凝胶/辐射图像分析系统(ChemiDoc XRS);方法:这项研究是在2006年11月至2007年7月之间在重庆神经病学实验室进行的。将小鼠随机分为模型组和对照组,每组8只小鼠组。模型组的小鼠每周两次连续皮下注射MPTP(25mg / kg),连续五周,以建立慢性帕金森氏病模型。对照组小鼠在相同的时间点进行相同体积的皮下生理盐水注射。麻醉处死小鼠以快速获得用于分离黑质蛋白的中脑。主要观察指标:(1)二维电泳参考2-ED手册(Bio-Rad Company)。 (2)采用PDQUEST8.0分析电泳图谱评估差异蛋白的表达。 (3)在http://www.prospector.ucsf.edu上检索肽质量指纹图谱和数据,以比较两组中黑质黑质蛋白的差异表达。结果:黑质黑质组织的二维凝胶电泳表明存在两组之间有33种差异蛋白表达。评价了三种新蛋白,包括表达受调节的α-烯醇酶,肿瘤坏死因子配体超家族成员4和细胞周期蛋白依赖性激酶抑制剂1B。结论:三种蛋白在黑质-α-烯醇酶中表现出差异表达,肿瘤坏死因子配体超家族成员4和细胞周期蛋白依赖性激酶抑制剂1B。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号